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BACKGROUND: Diptheria cases are treated with both anti-diphtheria serum (ADS) and antibiotics. Penicillin and erythromycin are the primary choices 
for any Corynebacterium diphtheriae (C. diphtheriae) 
infection. Antibiotic susceptibility pattern of C. diphtheriae 
has not been reported in Indonesia since 1982. The improper 
use of  antibiotics,  as  well  as,  the  consumption  of 
antibiotics without prescription, will increase the resistance 
of C. diphtheriae. This study aims to determine the 
susceptibility pattern and the effectiveness of C. diphtheriae 
to several antibiotics.  
METHODS: A total of 57 C. diphtheriae isolates were 
recultured by using Blood Agar (BA) and Cystine Tellurite 
Blood Agar (CTBA). Afterward, these isolates were 
identified by using API Coryne. The antibiotic susceptibility 
pattern was determined by using Kirby Bauer Method based 
on CLSI M45-A2. 
RESULTS: These studies revealed that as the primary 
choice of diphtheria cases, 10.5% of C. diphtheriae isolates 
were resistant to Penicillin and 5.3% were resistant to 
erythromycin. Seven isolates (12%) showed resistance 
to more than one antibiotics, such as tetracycline and 
clindamycin, vancomycin and clindamycin, penicillin and 
tetracycline, also penicillin and vancomycin. Moreover, 4 
isolates (7%)  were resistant to 3-5 antibiotics. All isolates 
were susceptible to moxifloxacin and linezolid.
CONCLUSION: Some  C. diphtheriae  isolates  were 
resistant to penicillin and erythromycin, which are known 
as the primary choice for the treatment of  C. diphtheriae 
infection. Even though, all isolates susceptible to 
moxifloxacin and linezolid. 
KEywORDS: Corynebacterium diphtheriae,  resistance, 
antimicrobial 
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Abstract
Introduction
Diphtheria is a disease caused by Corynebacterium 
diphtheriae (C. diphtheriae). The primary virulence factor 
of C. diphtheriae is an endotoxin that is released by the 
bacteria once inside the human host. The target organs of 
this bacterium are tonsils, pharynx, larynx, nasal, mucous 
membranes and skin. The clinical symptoms of diphtheria 
are sore throat, membrane lesions in the throat with a 
tender cervical lymph nodes enlargement. Toxin production 
and colonization of C. diphtheriae should be considered 
in diphtheria infection. Diphtheria, Pertussis, Tetanus 
(DPT) immunization program has been implemented in 
some developing countries. It has been proven to reduce 
the incidence of diphtheria in the last three decades. Low 
coverage  of  DPT  immunization  will  increase  the  risk  of 
C. diphtheriae infection.(1-3)
 Currently, the recommended treatments of diphtheria 
are anti-diphtheria serum (ADS) and antibiotics, which 
are given simultaneously. The antitoxin will neutralize the 
unbound toxin that circulating in the blood and cell/tissue, 
while the antibiotic eliminate the bacteria. Consequently, 
it prevents toxin production and breaks the transmission 
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in communities. Penicillin and erythromycin are 
recommended antibiotics to treat diphtheria by the World 
Health Organization (WHO). However, it has been reported 
that there are C. diphtheriae which resistant to penicillin, 
oxacillin, erythromycin, rifampicin, tetracycline and 
clindamycin.(4-6). Another problem that has been identified 
in the treatment of diphtheria is the increase of multidrug 
resistance C. diphtheriae. Therefore, it is necessary to 
monitor the antimicrobial susceptibility of C. diphtheriae 
continuously.
 In 2008, 14.8% isolates of C. diphtheriae in Brazil 
showed resistance to penicillin G, even erythromycin and 
azithromycin were still effective, but the susceptibility to 
erythromycin had decreased.(6) Meanwhile, in Canada 
around 2011, multidrug resistant C. diphtheriae were 
isolated from a skin wound. These isolates were resistant 
to clindamycin and erythromycin.(7)  A study in Indonesia 
showed that C. diphtheriae is resistant to tetracycline since 
1982. During that time, 86% of 133 C. diphtheriae isolated 
from diphtheria patients were resistant to tetracycline.(8)
 The gold standard of antimicrobial susceptibility test 
for C. diphtheriae is broth microdilution method. However, 
this method is quite challenging and has some limitations, 
such as time-consuming, a high risk of contamination 
and more complicated rather than disk diffusion method. 
Disk diffusion is another alternative method to determine 
the antimicrobial susceptibility of  C. diphtheriae. This 
method is simpler, easier and cheaper. The reason for 
choosing Staphylococcus aureus and Streptococcus spp. as 
a susceptibility breakpoints for C. diphtheriae is because 
both of them are gram-positive bacteria.
 In Indonesia and other developing countries, antibiotics 
are available without a prescription. Consequently, the 
emergence of multidrug resistant C. diphtheriae become 
another problem in controlling diphtheria. The aim of 
this study is to determine the pattern of resistance and the 
effectiveness of some antibiotics against C. diphtheriae. This 
study presents the resistance pattern of mono and multidrug 
resistance C. diphtheriae to antibiotics that frequently used 
in diphtheria treatment in Indonesia.
Methods
Bacterial Isolates
Fifty-seven C. diphtheriae isolates were isolated from 
diphtheria outbreaks investigation in Indonesia during 
2010-2015. All isolates were obtained from nasopharynx 
and throat swab of diphtheria patients in several provinces. 
Twenty-four isolates are from Banten, 14 isolates are from 
West Kalimantan, 1 isolate is from West Java, 10 isolates 
are from Jakarta, 1 isolate is from Central Kalimantan and 
7 isolates are from East Java. All isolates were stored in 
Trypticase Soy Broth (TSB) with 20% glycerol, at -80°C. 
Laboratory examination was conducted at the Bacteriology 
Laboratory, Center for Biomedical and Basic Technology of 
Health, Ministry of Health Indonesia in January-December 
2015.
Re-culture and Antimicrobial Susceptibility Testing of 
C. diphtheriae
All isolates were recultured on Blood Agar (BA) and 
Cystine Tellurite Blood Agar (CTBA) medium. The isolates 
were reidentified by using API Coryne®. The susceptibility 
test was performed by disk diffusion method. Mueller 
Hinton agar medium containing 5% sheep blood was used 
in this method.(8-13) The antibiotic susceptibility test was 
performed by using disc diffusion method, based on Clinical 
and Laboratory Standards Institute (CLSI) M45. Medium 
that used in antibiotics susceptibility test was Mueller 
Hinton agar medium containing 5% sheep blood.(8-13)
 Antibiotics used in this antibiotic susceptibility testing 
were erythromycin (15 mg), rifampin (5 mg), linezolid (30 
mg), clindamycin (2 mg), moxifloxacin (5 mg), gentamicin (10 
mg), Trimethoprim-sulfamethoxazole, (15 mg), vancomycin 
(30 mg), tetracycline (30 mg) and benzylpenicillin (10 mg). 
There was no breakpoint criteria for C. diphtheriae, therefore 
in this study, the breakpoint referred to Streptococcus spp. 
for antibiotic other than penicillin, and Staphylococcus spp. 
for breakpoints of penicillin(6,7) We used Streptococcus 
pneumoniae  ATCC  49619  as  internal  quality  control  for 
C. diphtheriae antibacterial susceptibility testing.
Statistical Analysis and Ethical Approval
Data analysis of antimicrobial resistance pattern and profile 
was performed by using WHONET software version 5.6. 
The Ethical approval was obtained from Ethical Committee 
of National Institutes of Health Research and Development, 
Ministry of Health Indonesia, with the clearance number: 
LB.02.01/5.2/KE.315/2015.
Results
Biochemical identification of 57 reculture isolates on CTBA 
and BA was shown in Table 1. Meanwhile, the antimicrobial 
susceptibility pattern of 57 C. diphtheriae isolates by using 
disc diffusion method was shown in Table 2.
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Table 1. Biochemical identification confirmation.
Biochemical test 1*: nitrate reduction (+), pyrazinamidase (-), 
pyrrolidonyl arylamidase (-), alkaline phosphatase (-), beta 
glucuronidase (-), beta galactosidase (-), alpha glucosidase (-/+), 
N-acetyl-B glucosaminidase (-), esculin (-), urease (-), gelatine (-), 
glucose (+), ribose (-), xylose (-), mannitol (-), maltose (+), lactose 
(-), sucrose (-), glycogen (+), catalase (+),  hemolysis (+/-).   
Note:  (+): positive reaction
 (-): negative reaction
CTBA BA
57 Black 
colonies
White 
colonies
The metachromatic 
granules of 
Diphtheria bacilli
1*
Number of 
Sampels
Characteristics Colony 
After 24 -48 Hours Microscopic 
(Albert Stain's)
Biochemical 
Test 
Table 2. Susceptibility of C. diphtheriae to tested antibiotics.
 Fifteen C. diphtheriae isolates (26.3%) with no 
resistance are susceptible to all antibiotics tested and 42 
isolates are resistant to at least one antibiotic. The profile 
showed some isolates resistance to several antibiotics (multi 
resistant) (Table 3).
%R: Resistance Percentage, % I : Intermediate percentage, %S: 
Susceptible percentage, PEN: Penicillin G, MFX: Moxifloxacin, 
GEN: Gentamicin, VAN: Vancomycin, TCY: Tetracycline, 
CLI: Clindamycin, LNZ: Linezolid, RIF: Rifampicin, SXT: 
Trimethoprim/Sulfamethoxazole, ERY: Erythromycin.
Resistance Profile Number of Isolate % Isolate
NR 15 26
CLI 2 3.5
TCY 25 43.9
PEN 1 1.8
RIF 1 1.8
SXT 2 3.5
ERY 1 1.8
TCY,  CLI 1 1.8
VAN, CLI 1 1.8
VAN, TCY 3 5.3
PEN , VAN 1 1.8
PEN, TCY, CLI 1 1.8
PEN, GEN, VAN, TCY, CLI 3 5.3
Total 57 100%
Table 3. Profile of C.diphtheriae antibiotics resistance.
Discussion
NR: No resistance, CLI: Clindamycin, TCY: Tetracycline, 
PEN: Penicillin G, VAN: Vancomycin, GEN: Gentamicin, 
RIP: Rifampicin, SXT: Trimethoprim/Sulfamethoxazole, ERY: 
Erythromycin.
The purpose of antibiotic treatment for diphtheria cases is 
to eliminate bacteria from the infection site, consequently 
it will stop toxins production and the transmission of the 
disease in the community.(3) The antibiotic susceptibility 
testing is used to guide the antibiotics used in diphtheria 
cases. The appropriate use of antibiotic in diphtheria cases 
will inhibit the toxin production and prevent transmission 
from the patient or asymptomatic carrier to others.
 Table 2 shows that all 57 isolates are sensitive to 
moxifloxacin and linezolid. There are 84.2% C. diphtheriae 
isolates that resistant to tetracycline, 22.8% resistant 
trimethoprim-ssulfamethoxazole, 10.5% resistant to 
penicillin, 8.8% resistant to vancomycin, 5.3% resistant to 
erythromycin and 5.3% resistant to clindamycin.
 The   profile   of   antibiotic   susceptibility   result   of 
C. diphtheriae is shown on Table 3, there are some isolates 
that resistance to two or more antibiotics, commonly called 
as multidrug resistant bacterium. Irrational use of antibiotics 
due to misdiagnosis and misuse of antibacterial agent, will 
cause the occurrence of multidrug resistance.
 The literature of multi-drug resistant for C. diphtheriae 
are rarely found. Nevertheless, some study reported about 
multi-drug resistant C. diphtheriae isolates. There were 
20% of isolates in Vietnam resistant to some antibiotics by 
microdilution broth and disc diffusion.(7) A study conducted 
in Brazil showed that 97% of C. diphtheriae strains are 
resistant to 4-7 antimicrobials, including mupirocin, penicilin 
and/or ampicillin, oxacillin, ceftazidime, aztreonam, 
tetracycline and/or lincomycin, clindamycin, erythromycin. 
Those studies used disc diffusion and E-test methods.(6) 
On the contrary, the susceptibility data collected from an 
outbreak in Russian Federation in the early 1990s showed 
that 2.4% isolates had monoresistance to trimethoprim and 
rifampin but no isolates as multidrug resistant was found. 
It also reported from a study in Polish, whereas there was a 
multidrug resistance C. diphtheriae case in Canada which 
Antibiotic Dose n %R %I %S
PEN 10 µg 57 11 5 84
MFX 5µg 57 0 0 100
GEN 10 µg 57 1.8 3.5 94.7
VAN 30 µg 57 8.8 5.3 86
TCY 30 µg 57 84.2 7 8.8
CLI 2 µg 57 5.3 5.3 89.5
LNZ 30 µg 57 0 0 100
RIF 5 µg 57 1.8 0 98.2
SXT 1,25/23,75 57 22.8 0 77.2
ERY 15 µg 57 5.3 3.5 91.2
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was resistant to clindamycin, erythromycin, tetracycline and 
trimethoprim-sulfamethoxazole.(7,17-20)
 In our study, there were 6  isolates (10.5%) that 
resistance to two antibiotics, such as tetracycline and 
clindamycin, vancomycin and clindamycin, vancomycin 
and tetracycline,  also penicillin and vancomycin. Then 
4  isolates  (7%) resistance to 3-5 antibiotics. All isolates 
susceptible to moxifloxacin and linezolid and 15 out of 
57 C. diphtheriae isolates (26.3%) are susceptible to all 
antimicrobials tested. 
 A study conducted in Cipto Mangunkusumo Hospital, 
Jakarta in 1982 reported that 33 out of 188 samples are 
identified as C. diphtheriae subtype mitis.(8) All isolates 
were tested by disc diffusion and E-test, simultaneously. It 
showed that the agreement value between disc diffusion and 
E-test method were 94.9%.(6)
 Tetracycline resistance C. diphtheriae is uncommon 
in some countries, but some study in Europe countries 
revealed C. diphtheriae that resistant to tetracycline, 
after treatment of intravenous tetracycline. Tetracycline 
resistance C. diphtheriae was also reported in 1982 in 
Cipto Mangunkusumo Hospital, Jakarta. In that study, 
133 samples (86%) showed resistance to tetracycline.(10) 
Moreover, the study reported all the isolates susceptible to 
penicillin and erythromycin. It study have similarity with 
our research, especially in tetracycline resistance. On the 
contrary, the research of susceptibility test in Brazil reported 
that 12.8% out of 47 isolates of C. diphtheriae was resistant 
to tetracycline, by using minimum inhibitory concentration 
(MIC) method.
 The mechanism of tetracycline-resistant due to 
different cytoplasmic membrane generates and prevents 
binding of tetracycline to the 30s ribosomal subunit, then 
the protein synthesis of the cytoplasmic membrane can 
continue. Another tetracycline-resistant mechanism is efflux 
pump due to mutation of tetAB genes, this mechanism 
enables the bacteria pump the antibiotic out of the cell. This 
mechanism prevents tetracycline accumulate within the 
bacteria in toxic level so the bacterial protein synthesis will 
not be inhibited.(14,15)
 In  this  study,  10.5%  C. diphtheriae  isolates 
resistant  to  penicillin  and  5.3%  resistant to erythromycin. 
The  previous study  in  1982  with  the  same method 
showed   that  C. diphtheriae still susceptible to penicillin 
and erythromycin. Another study in French and Poland 
showed that 42 C. diphtheriae isolates were susceptible 
to erythromycin and 6 of them have the decreased 
susceptibility to penicillin. Essentially, the in vitro activity 
of erythromycin is better than penicillin.(16)
 Some studies reveal that some C. diphtheriae 
isolates are resistant to some drugs, such as penicillin 
G, oxacillin and other antibiotics which are used for the 
treatment of diphtheria, for instance rifampin, tetracycline 
and clindamycin. The presence of b-lactams resistance 
against C. diphtheriae should be concerned, especially 
in the administration of penicillin for patients who have 
endocarditis because of C. diphtheriae infections. It could 
increase the risk of treatment failure.(6) A study in Brazilian 
reported that a patient with endocarditis bacterialis caused 
by multidrugs resistance C. diphtheriae infection was 
showing a treatment failure. Based on the study, clinician 
must reconsider  the  use  of  resistant  to  b-lactams 
antibiotic  if  the  clinical  condition  of  patient  with 
systemic  infection does not improve after being treated 
with b-lactams antibiotics.(6)
 According to CLSI document M45-A2 guideline, 
the  microdilution  broth  method  is  recommended   in 
C.  diphtheriae susceptibility testing. We already conducted 
our research with this method by using an automated 
reading incubation system (ARIS) (Thermo Scientific, 
Massachusetts, USA) to determine dentification and 
antimicrobial susceptibility testing of C. diphtehriae, 
nevertheless there are several limitations of the sensititre 
ARIS. First, it only detects genus level of corynebacterium 
species. Second, the breakpoints of determining of the 
antibiotic concentration have small range values. Therefore, 
when examining Streptococcus pneumoniae ATCC 49619 
as a validity test, the results are out of the range. Third, 
the sensititre plate with lysed horse blood medium for 
C. diphtheriae antimicrobial susceptibility testing  is 
not available in Indonesia. We already optimatized an in 
house plate by adding lysed horse blood manually, but 
the result was not satisfying. We also tried antimicrobial 
susceptibility testing by using strip diffusion agar, such as 
E-test® (Biomeureux, Marcy-l'Étoile, France) and Ezy® 
test (Himedia, Mumbai, India), but those products are out 
of stock for several months in Indonesia. Therefore, we use 
disc diffusion method as an alternative, because it is easier 
and cheaper compare to others method and is available in 
Indonesia.
 C. diphthteriae have several resistance mechanisms 
which  are  related  to  mutations  in  particular  genes. 
C. diphtheriae resistant erythromycin mechanism relates 
to a mutation in ErmX genes which is expressed in methyl 
transferase enzymes. Resistance to tetracycline relates 
to teM and tetAB genes mutation. C. diphtheriae that 
resistant to penicillin occurred as a result of mutation in 
genes encoded penicillin-binding protein or due to bacterial 
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Conclusion
genes required penicillin-binding protein. Penicillin 
resistant C. diphtheriae may also occur due to the limited 
of bacteria transport system in the outer membrane which 
prevents penicillin reach cytoplasmic membrane where the 
penicillin-binding protein located. Vancomycin resistance 
occurs due to the enzyme in bacteria resistant cells. The 
mechanism of resistance identified in the Tn1546-based 
antibiotic resistance was shown to involve alteration of 
this dipeptide residue from D-ala-D-ala to d-alanyld-lactate 
(D-ala-D-lac), a dipeptide with substantially lower affinity 
for the antibiotic.(14,15)
Based on this study, some of C.diphtheriae are resistant 
to several antibiotics that used as primary choice of 
diphtheria. C.diphtheriae is resistant to penicillin (10.5%) 
and erythromycin (5.3%). It is also identified that there are 
6 isolates (10,5%) that are resistant to two other antibiotics 
such as tetracycline and clindamycin, vancomycin and 
clindamycin, vancomycin and tetracycline,  also penicillin 
and vancomycin. Then, 4 isolates (7%) are found to 
be resistance to 3-5 antimicrobial. Only moxifloxacin 
and linezolid show 100% susceptible and 14 out of 57 
C.diphtheriae isolates (25%) are susceptible to all antibiotics 
tested.  Those results could be used as a recommendation for 
diphtheria treatment guidelines in Indonesia.References
1. Fricchione MJ, Deyro HJ, Jensen CY, Hoffman JF, Singh K, 
Logan LK. Non-toxigenic penisilin and cephalosporin-resistant 
corynebacterium diphtheriae endocarditis in a child: A case report 
and  review  of  the  literature.  J Pediatric Infect Dis Soc. 2014; 3: 
251-4. 
2. Guilfoile PG. Deadly diseases and epidemics: diphtheria. New York: 
Chelsea House Publishers; 2009.
3. Rudi HP, Sariadji K, Sunarno, Roselinda. Corynebacterium 
diphtheriae Diagnosis Laboratorium Bakteriologi. 1st edition. 
Jakarta: Yayasan Pustaka Obor Indonesia; 2014.
4. De Zoysa A, Efstratieu A. Corynebacterium spp. In: Gillespie 
SH, Hawkey PM, editors. Principles and Practice of Clinical 
Bacteriology. 2nd edition. USA: John Wiley & Son; 2006.
5. Lumio J. Studies on the epidemiology and clinical characteristics of 
diphteria during the russian epidemic of the 1990s [Dissertation]. 
Finlandia: University of  Tampere; 2003.
6. Pereira GA, Pimenta FP, Santos FR, Damasco PV, Hirata Júnior R, 
Mattos-Guaraldi AL. Antimicrobial resistance among Brazilian 
Corynebacterium diphtheriae strains. Mem Inst Oswaldo Cruz. 
2008; 103: 507-10.
7. Mina NV, Burdz T, Wiebe D, Rai JS, Rahim T, Shing F, et al. Canada's 
first case of a multidrug-resistant Corynebacterium diphtheriae 
strain, isolated from a skin abscess. J Clin Microbiol. 2011; 49: 
4003-5.
8. Rockhill RC, Sumarmo, Hadiputranto H, Siregar SP, Muslihun B. 
Tetrasiklin resistance of Corynebacterium diphtheriae isolated 
from diphtheria patients in Jakarta, Indonesia. Antimicrob Agents 
Chemother. 1982; 21: 842-3.
9. Clinical and Laboratory Standards Institute. Methods for Antimicrobial 
Dilution and Disk Susceptibility Testing of Infrequently Isolated or 
Fastidious Bacteria. CLSI document M45-A2. Wayne, PA: Clinical 
and Laboratory Standards Institute; 2010.
10. Clinical and Laboratory Standards Institute. Performance Standars 
for  Susceptibility Testing, Twenty Fifth Informational Supplement. 
CLSI document M100-S25. Wayne, PA: Clinical and Laboratory 
Standards Institute; 2015.
11. Efstratiou A, George RC. Laboratory guidelines for the diagnosis of 
infections caused by C.diphtheriae and C. ulcerans. Commun Dis 
Public Health. 1999: 2: 250-7.
12. Efstratiou A, Engler KH, Mazurova IK, Glushkevich T, Vuopio-
Varkila J, Popovic T. Current approaches to the laboratory diagnosis 
of diphtheria. J Infect Dis. 2000; 181(Suppl 1): S138-45. 
13. Efstratiou A, Maple PAC. WHO Manual for the Laboratory Diagnosis 
of Diphtheria. Copenhagen: WHO Region Office for Europe; 1994.
14. Pana M. Antibiotic Resistant Bacteria – A Continuous Challenge in 
the New Millennium. Croatia: InTech; 2012. 
15. Pratiwi ST. Mikrobiologi Farmasi. Jakarta: Erlangga; 2012.
16.  Farfour E,  Badell E,  Zasada A, Hotzel H, Tomaso H,  Guillot S, Guiso 
N. Characterization and comparison of invasive corynebacterium 
diphtheriae isolates from France and Poland. J Clin Microbiol. 
2012; 50: 173-5. 
17.  Burkovski A. Corynebacterium diphtheria and Related Toxigenic 
Species. Netherland: Springer; 2014. 
18.  Roca I, Akova M,  Baquero F,  Carlet J, Cavaleri M,  Coenen S. The 
global threat of antimicrobial resistance: science for intervention. 
New Microbe and New Infect. 2015; 6: 22-9.
19. Ventola Lee C. The antibiotic resistance crisis. P&T. 2015; 40: 277-
83.
20. Bell M. Antibiotic misuse a global crisis. JAMA. 2014; 174: 1920-1.
